Cyclophosphamide versus placebo in scleroderma lung disease
- Author
- TASHKIN, Donald P1 ; ELASHOFF, Robert1 ; SEIBOLD, James R3 ; RILEY, David J3 ; HSU, Vivien M3 ; VARGA, John4 ; SCHRAUFNAGEL, Dean E4 ; THEODORE, Arthur5 ; SIMMS, Robert5 ; WISE, Robert6 ; WIGLEY, Fredrick6 ; WHITE, Barbara6 ; CLEMENTS, Philip J1 ; STEEN, Virginia7 ; READ, Charles7 ; MAYES, Maureen8 ; PARSLEY, Ed8 ; MUBARAK, Kamal9 ; KARI CONNOLLY, M10 ; GOLDEN, Jeffrey10 ; OLMAN, Mitchell11 ; FESSLER, Barri11 ; ROTHFIELD, Naomi12 ; GOLDIN, Jonathan1 ; METERSKY, Mark12 ; ROTH, Michael D1 ; FURST, Daniel E1 ; ARRIOLA, Edgar1 ; SILVER, Richard2 ; STRANGE, Charlie2 ; BOLSTER, Marcy2
[1] University of California at Los Angeles, Los Angeles, United States
[2] Medical University of South Carolina, Charleston, United States
[3] University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, United States
[4] University of Illinois, Chicago, United States
[5] Boston University, Boston, United States
[6] Johns Hopkins School of Medicine, Baltimore, United States
[7] Georgetown University, Washington, D.C, United States
[8] University of Texas at Houston Medical School, Houston, United States
[9] Wayne State University, Detroit, United States
[10] University of California San Francisco, San Francisco, United States
[11] University of Alabama, Birmingham, United States
[12] University of Connecticut Health Center, Farmington, United States
Scleroderma Lung Study Research Group, United States - Source
The New England journal of medicine. 2006, Vol 354, Num 25, pp 2655-2666, 12 p ; ref : 34 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Boston, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Cyclophosphamide Etude comparative Médecine Placebo Poumon pathologie Sclérodermie Agent alkylant Appareil respiratoire pathologie Immunopathologie Maladie autoimmune Maladie système Moutarde à l'azote Oxazaphosphinane dérivé Peau pathologie Tissu conjonctif pathologie
- Keyword (en)
- Antineoplastic agent Cyclophosphamide Comparative study Medicine Placebo Lung disease Scleroderma Alkylating agent Respiratory disease Immunopathology Autoimmune disease Systemic disease Nitrogen mustard Oxazaphosphinane derivatives Skin disease Connective tissue disease
- Keyword (es)
- Anticanceroso Ciclofosfamida Estudio comparativo Medicina Placebo Pulmón patología Esclerodermia Agente alquilante Aparato respiratorio patología Inmunopatología Enfermedad autoinmune Enfermedad sistémica Mostaza al nitrógeno Oxazafosfinano derivado Piel patología Tejido conjuntivo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B07 Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
- Discipline
- Generalities in medical sciences Sarcoidosis. Granulomatosis of undetermined origin. Connective tissue diseases. Vasculitides
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17877664
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa055120 
https://dx.doi.org/10.1056/NEJMoa055120
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa055120\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"2655\";s:8:\"\u0000*\u0000epage\";s:4:\"2666\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TASHKIN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Donald P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:30:{i:0;s:16:\"ELASHOFF, Robert\";i:1;s:16:\"SEIBOLD, James R\";i:2;s:14:\"RILEY, David J\";i:3;s:13:\"HSU, Vivien M\";i:4;s:11:\"VARGA, John\";i:5;s:20:\"SCHRAUFNAGEL, Dean E\";i:6;s:16:\"THEODORE, Arthur\";i:7;s:13:\"SIMMS, Robert\";i:8;s:12:\"WISE, Robert\";i:9;s:16:\"WIGLEY, Fredrick\";i:10;s:14:\"WHITE, Barbara\";i:11;s:18:\"CLEMENTS, Philip J\";i:12;s:15:\"STEEN, Virginia\";i:13;s:13:\"READ, Charles\";i:14;s:14:\"MAYES, Maureen\";i:15;s:11:\"PARSLEY, Ed\";i:16;s:14:\"MUBARAK, Kamal\";i:17;s:16:\"KARI CONNOLLY, M\";i:18;s:15:\"GOLDEN, Jeffrey\";i:19;s:15:\"OLMAN, Mitchell\";i:20;s:14:\"FESSLER, Barri\";i:21;s:16:\"ROTHFIELD, Naomi\";i:22;s:16:\"GOLDIN, Jonathan\";i:23;s:14:\"METERSKY, Mark\";i:24;s:15:\"ROTH, Michael D\";i:25;s:15:\"FURST, Daniel E\";i:26;s:14:\"ARRIOLA, Edgar\";i:27;s:15:\"SILVER, Richard\";i:28;s:16:\"STRANGE, Charlie\";i:29;s:14:\"BOLSTER, Marcy\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa055120\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"2655\";s:8:\"\u0000*\u0000epage\";s:4:\"2666\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TASHKIN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Donald P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:30:{i:0;s:16:\"ELASHOFF, Robert\";i:1;s:16:\"SEIBOLD, James R\";i:2;s:14:\"RILEY, David J\";i:3;s:13:\"HSU, Vivien M\";i:4;s:11:\"VARGA, John\";i:5;s:20:\"SCHRAUFNAGEL, Dean E\";i:6;s:16:\"THEODORE, Arthur\";i:7;s:13:\"SIMMS, Robert\";i:8;s:12:\"WISE, Robert\";i:9;s:16:\"WIGLEY, Fredrick\";i:10;s:14:\"WHITE, Barbara\";i:11;s:18:\"CLEMENTS, Philip J\";i:12;s:15:\"STEEN, Virginia\";i:13;s:13:\"READ, Charles\";i:14;s:14:\"MAYES, Maureen\";i:15;s:11:\"PARSLEY, Ed\";i:16;s:14:\"MUBARAK, Kamal\";i:17;s:16:\"KARI CONNOLLY, M\";i:18;s:15:\"GOLDEN, Jeffrey\";i:19;s:15:\"OLMAN, Mitchell\";i:20;s:14:\"FESSLER, Barri\";i:21;s:16:\"ROTHFIELD, Naomi\";i:22;s:16:\"GOLDIN, Jonathan\";i:23;s:14:\"METERSKY, Mark\";i:24;s:15:\"ROTH, Michael D\";i:25;s:15:\"FURST, Daniel E\";i:26;s:14:\"ARRIOLA, Edgar\";i:27;s:15:\"SILVER, Richard\";i:28;s:16:\"STRANGE, Charlie\";i:29;s:14:\"BOLSTER, Marcy\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa055120\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa055120\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"2655\";s:8:\"\u0000*\u0000epage\";s:4:\"2666\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TASHKIN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Donald P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:30:{i:0;s:16:\"ELASHOFF, Robert\";i:1;s:16:\"SEIBOLD, James R\";i:2;s:14:\"RILEY, David J\";i:3;s:13:\"HSU, Vivien M\";i:4;s:11:\"VARGA, John\";i:5;s:20:\"SCHRAUFNAGEL, Dean E\";i:6;s:16:\"THEODORE, Arthur\";i:7;s:13:\"SIMMS, Robert\";i:8;s:12:\"WISE, Robert\";i:9;s:16:\"WIGLEY, Fredrick\";i:10;s:14:\"WHITE, Barbara\";i:11;s:18:\"CLEMENTS, Philip J\";i:12;s:15:\"STEEN, Virginia\";i:13;s:13:\"READ, Charles\";i:14;s:14:\"MAYES, Maureen\";i:15;s:11:\"PARSLEY, Ed\";i:16;s:14:\"MUBARAK, Kamal\";i:17;s:16:\"KARI CONNOLLY, M\";i:18;s:15:\"GOLDEN, Jeffrey\";i:19;s:15:\"OLMAN, Mitchell\";i:20;s:14:\"FESSLER, Barri\";i:21;s:16:\"ROTHFIELD, Naomi\";i:22;s:16:\"GOLDIN, Jonathan\";i:23;s:14:\"METERSKY, Mark\";i:24;s:15:\"ROTH, Michael D\";i:25;s:15:\"FURST, Daniel E\";i:26;s:14:\"ARRIOLA, Edgar\";i:27;s:15:\"SILVER, Richard\";i:28;s:16:\"STRANGE, Charlie\";i:29;s:14:\"BOLSTER, Marcy\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa055120\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"2655\";s:8:\"\u0000*\u0000epage\";s:4:\"2666\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TASHKIN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Donald P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:30:{i:0;s:16:\"ELASHOFF, Robert\";i:1;s:16:\"SEIBOLD, James R\";i:2;s:14:\"RILEY, David J\";i:3;s:13:\"HSU, Vivien M\";i:4;s:11:\"VARGA, John\";i:5;s:20:\"SCHRAUFNAGEL, Dean E\";i:6;s:16:\"THEODORE, Arthur\";i:7;s:13:\"SIMMS, Robert\";i:8;s:12:\"WISE, Robert\";i:9;s:16:\"WIGLEY, Fredrick\";i:10;s:14:\"WHITE, Barbara\";i:11;s:18:\"CLEMENTS, Philip J\";i:12;s:15:\"STEEN, Virginia\";i:13;s:13:\"READ, Charles\";i:14;s:14:\"MAYES, Maureen\";i:15;s:11:\"PARSLEY, Ed\";i:16;s:14:\"MUBARAK, Kamal\";i:17;s:16:\"KARI CONNOLLY, M\";i:18;s:15:\"GOLDEN, Jeffrey\";i:19;s:15:\"OLMAN, Mitchell\";i:20;s:14:\"FESSLER, Barri\";i:21;s:16:\"ROTHFIELD, Naomi\";i:22;s:16:\"GOLDIN, Jonathan\";i:23;s:14:\"METERSKY, Mark\";i:24;s:15:\"ROTH, Michael D\";i:25;s:15:\"FURST, Daniel E\";i:26;s:14:\"ARRIOLA, Edgar\";i:27;s:15:\"SILVER, Richard\";i:28;s:16:\"STRANGE, Charlie\";i:29;s:14:\"BOLSTER, Marcy\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa055120\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"2655\";s:8:\"\u0000*\u0000epage\";s:4:\"2666\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TASHKIN\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Donald P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:30:{i:0;s:16:\"ELASHOFF, Robert\";i:1;s:16:\"SEIBOLD, James R\";i:2;s:14:\"RILEY, David J\";i:3;s:13:\"HSU, Vivien M\";i:4;s:11:\"VARGA, John\";i:5;s:20:\"SCHRAUFNAGEL, Dean E\";i:6;s:16:\"THEODORE, Arthur\";i:7;s:13:\"SIMMS, Robert\";i:8;s:12:\"WISE, Robert\";i:9;s:16:\"WIGLEY, Fredrick\";i:10;s:14:\"WHITE, Barbara\";i:11;s:18:\"CLEMENTS, Philip J\";i:12;s:15:\"STEEN, Virginia\";i:13;s:13:\"READ, Charles\";i:14;s:14:\"MAYES, Maureen\";i:15;s:11:\"PARSLEY, Ed\";i:16;s:14:\"MUBARAK, Kamal\";i:17;s:16:\"KARI CONNOLLY, M\";i:18;s:15:\"GOLDEN, Jeffrey\";i:19;s:15:\"OLMAN, Mitchell\";i:20;s:14:\"FESSLER, Barri\";i:21;s:16:\"ROTHFIELD, Naomi\";i:22;s:16:\"GOLDIN, Jonathan\";i:23;s:14:\"METERSKY, Mark\";i:24;s:15:\"ROTH, Michael D\";i:25;s:15:\"FURST, Daniel E\";i:26;s:14:\"ARRIOLA, Edgar\";i:27;s:15:\"SILVER, Richard\";i:28;s:16:\"STRANGE, Charlie\";i:29;s:14:\"BOLSTER, Marcy\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:59:\"Cyclophosphamide versus placebo in scleroderma lung disease\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
